Morelo-Lora UÁ, Armas-Pedrosa G, Paz-Estrada C, Pías-Solís S

Language: Spanish
References: 12
Page: 76-79
PDF size: 375.79 Kb.

ABSTRACT

Objective: to evaluate the analgesic quality of intrathecal morphine at different postoperative doses. Material and methods: a sample of 50 hysterectomy patients divided into two double-blind groups was used, using bupivacaine at 0.5% 10 mg plus morphine, at two different doses of 0.3 and 0.5 mg, where the predominant age of the patients was more than 40 years, a classification of the functional status of group II ASA, the presence of co-morbidities mainly hypertension in a high number of patients although compensated. Results: the adverse effects found were nausea, vomiting and light pruritus; which predominated in group II. However, the patients in this group showed better pain quality, less use of analgesia for rescue in the postoperative period and a higher degree of satisfaction, so the dose used in them was the most effective. Conclusions: the results of this research allow the use of intrathecal morphine as an anesthetic method in hysterectomies to control postoperative pain at the indicated doses.

REFERENCES

1. Primavesi AB. Morfina peridural: analgésico pós-operatório. Braz J Anesthesiol. 1986;36:299-302.

2. Fascio MN, Pinto MC. Injeção peridural de morfina no tratamento da dor. Braz J Anesthesiol. 1980;30:255-256.

3. Nocite JR, Cagnolati CA, Nunes AM, Souza LR. Morfina peridural no controle da dor pós-operatória. Braz J Anesthesiol.1982;32:57-64.

4. Nocite JR, Nuñez AM, Carvalho G, Oliveira DJ. Bloqueo subaracnoideo con bupivacaína pesada a 0,5%: efeito da adição de morfina à solução. Braz J Anesthesiol. 1985;35:S23-S29.

5. Moen M. Hysterectomy for benign conditions of the uterus: total abdominal hysterectomy. Obstet Gynecol Clin North Am. 2016;43:431-440.

6. Rahman R, Gupta S, Manyonda I. Hysterectomy for benign gynaecological disease. Obstet Gynaecol Reprod Med. 2017;27:125-131.

7. Pynna K, Vuorela P, Lodenius L, Paavonen J, Roine RP, Rasanen P. Cost-effectiveness of hysterectomy for benign gynecological conditions: a systematic review. Acta Obstet Gynecol Scand. 2014;93:225-232.

8. García-Montes JM, Lizcano-Contreras CT, Torres M, Álvarez-Hernández LF, Martínez-Sánchez LM, Vallejo-Agudelo E. Efectividad analgésica de clonidina vs. morfina como coadyuvantes de la anestesia espinal con bupivacaína hiperbárica en pacientes sometidas a cesárea. Rev Soc Esp Dolor. 2018;25:207-213.

9. Herrera Gómez PJ, Garzón JF. Opiáceos intratecales y depresión respiratoria ¿Un mito en obstetricia? Rev Colomb Anestesiol. 2015;43:101-103.

10. Osorio-Gutiérrez CI, Ortiz-Gómez GA, Valencia-Ríosa JF, Arango-Gómez FA. Comparación de mezcla de opioides subaracnoideos para cesárea. Estudio observacional. Rev Colomb Anestesiol. 2021;49:e940.

11. Blanton E, Lamvu G, Patanwala I, Barron KI, Witzeman K, Tu FF, et al. Non-opioid pain management in benign minimally invasive hysterectomy: A systematic review. Am J Obstet Gynecol. 2017;216:557-567.

12. Romero VK, Cazull II, González LL. Evaluación económica del tratamiento antimicrobiano en pacientes histerectomizadas por fibroma uterino. Rev Chil Obstet Ginecol. 2015;80:434-441.